FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and concerns normalisation of antiplasmin alpha-2 level in arterial hypertension (AH) with impaired glucose tolerance. That is ensured by complex treatment involving graduated physical activities, and introduction of pioglitazone in a dose 30 mg once a day in the morning and lisinopril in a dose 10 mg once a day in the morning within 1.5 months.
EFFECT: such complex of specific pharmacological preparations combined with drug-free modalities, as well as fitted duration of treatment provide reduced risk of thrombotic complications that is ensured by normalisation and correction of antiplasmin alpha-2 level, thereby fibrinolytic systems in the given group of patients.
3 ex, 1 tbl
